| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| 100mg |
|
||
| Other Sizes |
|
| ln Vitro |
SK33 exhibited notable and strong action in LNCaPAR+ cells, with an IC50 of 0.2 μM. LNCaP cell progression into the S phase is inhibited by SK33. SK33 treatment of LNCaP/BicR cells for 96 hours at increasing doses resulted in a dose-dependent response and a growth inhibition of the cells with an IC50 of about 5 μM [1].
|
|---|---|
| ln Vivo |
SK33 suppresses the transcriptional activity of AR (50 mg/kg; subcutaneous injection; 24 hours) [1].
|
| Cell Assay |
Cell Viability Assay[1]
Cell Types: LNCaP/BicR Cell Tested Concentrations: 0.1-100 μM Incubation Duration: 96 hrs (hours) Experimental Results: Produce a dose-dependent response and inhibit cell growth. |
| Animal Protocol |
Animal/Disease Models: ARE-Luc mice [1]
Doses: 50 mg/kg Route of Administration: subcutaneous injection; 24-hour Experimental Results: AR transcription activity was inhibited. |
| References |
| Molecular Formula |
C20H13F9N2O3
|
|---|---|
| Molecular Weight |
500.3145
|
| Exact Mass |
500.078
|
| CAS # |
1928724-23-5
|
| PubChem CID |
127043517
|
| Appearance |
White to off-white solid powder
|
| LogP |
4.7
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
13
|
| Rotatable Bond Count |
5
|
| Heavy Atom Count |
34
|
| Complexity |
752
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
FC(C1C([H])=C(C(F)(F)F)C([H])=C(C=1[H])OC([H])([H])C(C([H])([H])[H])(C(N([H])C1C([H])=C([H])C(C#N)=C(C(F)(F)F)C=1[H])=O)O[H])(F)F
|
| InChi Key |
VJIVKRQGSGBLFP-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C20H13F9N2O3/c1-17(33,16(32)31-13-3-2-10(8-30)15(7-13)20(27,28)29)9-34-14-5-11(18(21,22)23)4-12(6-14)19(24,25)26/h2-7,33H,9H2,1H3,(H,31,32)
|
| Chemical Name |
3-[3,5-bis(trifluoromethyl)phenoxy]-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
|
| Synonyms |
SK 33; SK-33
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~199.88 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.00 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.00 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.9988 mL | 9.9938 mL | 19.9876 mL | |
| 5 mM | 0.3998 mL | 1.9988 mL | 3.9975 mL | |
| 10 mM | 0.1999 mL | 0.9994 mL | 1.9988 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
